Evocalcet
Evocalcet (trade name Orkedia) is a drug for the treatment of hyperparathyroidism. It acts as a calcium-sensing receptor agonist. In 2018, it was approved in Japan for treatment of secondary hyperparathyroidism in patients on dialysis.
Wikipedia contributors, "Evocalcet", Wikipedia, revision 1330817259, retrieved 20 November 2026, source, CC BY-SA 4.0.